Nektar Therapeutics
NKTR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000906709
In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 3 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Nektar Therapeutics as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- −19 vs. Q4 2022
- Shares held
- 172.7M
- +3.89M (+2.3%) vs. Q4 2022
- Total value
- $121.2M
- −$260.3M (−68.2%) vs. Q4 2022
- New holders
- 20
- 56 more added
- Sold out
- 39
- 68 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 239 | $2.50B |
| Q1 2026 | 216 | $1.94B |
| Q4 2025 | 180 | $732.2M |
| Q3 2025 | 153 | $820.2M |
| Q2 2025 | 109 | $197.7M |
| Q1 2025 | 157 | $84.2M |
| Q4 2024 | 146 | $123.6M |
| Q3 2024 | 140 | $182.9M |
| Q2 2024 | 135 | $168.0M |
| Q1 2024 | 123 | $105.5M |
| Q4 2023 | 127 | $67.3M |
| Q3 2023 | 139 | $85.3M |
| Q2 2023 | 148 | $79.3M |
| Q1 2023 | 197 | $121.2M |
| Q4 2022 | 217 | $381.7M |
| Q3 2022 | 232 | $561.4M |
| Q2 2022 | 230 | $693.8M |
| Q1 2022 | 243 | $947.6M |
| Q4 2021 | 242 | $2.35B |
| Q3 2021 | 243 | $3.01B |
| Q2 2021 | 243 | $2.89B |
| Q1 2021 | 239 | $3.40B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Nektar Therapeutics; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −492,500−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −387,500−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −347,612−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −259,677−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −252,688−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −188,869−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −163,652−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −105,240−100.0% | Sold out |
| Empire Life Investments Inc. | 0 | $0 | 0.00% | −100,945−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −77,479−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −69,500−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −55,062−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −54,420−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −37,200−100.0% | Sold out |
| Swiss Life Asset Management Ltd | 0 | $0 | 0.00% | −36,707−100.0% | Sold out |
| Klingman & Associates, LLC | 0 | $0 | 0.00% | −35,063−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −34,076−100.0% | Sold out |
| Everence Capital Management Inc | 0 | $0 | 0.00% | −29,760−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −24,423−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −20,604−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,701−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,394−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| ISAM Funds (UK) Ltd | 0 | $0 | 0.00% | −14,780−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −14,333−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −13,942−100.0% | Sold out |
| Advisor Partners II, LLC | 0 | $0 | 0.00% | −10,210−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −3,145−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −1,246−100.0% | Sold out |
| DecisionPoint Financial, LLC | 0 | $0 | 0.00% | −933−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −793−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −237−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |